
Martin Reck, MD, PhD, Head of Thoracic Oncology, Hospital Grosshansdorf, discusses the phase III SQUIRE trial in patients with non-small cell lung cancer (NSCLC) treated with necitumumab.

Your AI-Trained Oncology Knowledge Connection!


Published: July 28th 2015 | Updated: